Literature DB >> 1719544

Trans splicing in trypanosomes requires methylation of the 5' end of the spliced leader RNA.

E Ullu1, C Tschudi.   

Abstract

Trypanosoma brucei spliced leader (SL) RNA contains an unusual cap 4 structure consisting of 7-methylguanosine linked to four modified nucleosides. During RNA maturation, trans splicing transfers the first 39 nucleotides of the SL RNA including the cap structure to the 5' end of all mRNAs. Here we show that exposure of permeable trypanosome cells to S-adenosyl-L-homocysteine inhibits methylation of the nucleosides adjacent to 7-methylguanosine of newly synthesized SL RNA and prevents utilization of the SL RNA in trans splicing. However, trans splicing of the SL RNA preexisting in the cells is not inhibited by S-adenosyl-L-homocysteine as shown by the observation that newly synthesized alpha-tubulin RNA is trans spliced at the same level as in control cells. Therefore, it appears that the newly synthesized SL RNA is the only known component of the trans-splicing machinery that is impaired in its function by inhibition of methylation. Undermethylation does not alter either the stability of the SL RNA or the electrophoretic mobility and chromatographic behavior of the core SL ribonucleoprotein particle. Taken together, our data suggest that the cap 4 structure of the SL RNA plays an essential role in the trans-splicing process.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719544      PMCID: PMC52870          DOI: 10.1073/pnas.88.22.10074

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Spliced leader RNA sequences can substitute for the essential 5' end of U1 RNA during splicing in a mammalian in vitro system.

Authors:  J P Bruzik; J A Steitz
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

2.  An essential signaling role for the m3G cap in the transport of U1 snRNP to the nucleus.

Authors:  U Fischer; R Lührmann
Journal:  Science       Date:  1990-08-17       Impact factor: 47.728

3.  Permeable trypanosome cells as a model system for transcription and trans-splicing.

Authors:  E Ullu; C Tschudi
Journal:  Nucleic Acids Res       Date:  1990-06-11       Impact factor: 16.971

4.  Direct analysis of the mini-exon donor RNA of Trypanosoma brucei: detection of a novel cap structure also present in messenger RNA.

Authors:  M S Freistadt; G A Cross; A D Branch; H D Robertson
Journal:  Nucleic Acids Res       Date:  1987-12-10       Impact factor: 16.971

Review 5.  Minor components in transfer RNA: their characterization, location, and function.

Authors:  S Nishimura
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  1972

6.  Discontinuously synthesized mRNA from Trypanosoma brucei contains the highly methylated 5' cap structure, m7GpppA*A*C(2'-O)mU*A.

Authors:  M S Freistadt; G A Cross; H D Robertson
Journal:  J Biol Chem       Date:  1988-10-15       Impact factor: 5.157

7.  mRNA(nucleoside-2'-)-methyltransferase from vaccinia virus. Purification and physical properties.

Authors:  E Barbosa; B Moss
Journal:  J Biol Chem       Date:  1978-11-10       Impact factor: 5.157

8.  Trypanosome mRNAs have unusual "cap 4" structures acquired by addition of a spliced leader.

Authors:  K L Perry; K P Watkins; N Agabian
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

Review 9.  Trans splicing in trypanosomes--archaism or adaptation?

Authors:  P W Laird
Journal:  Trends Genet       Date:  1989-07       Impact factor: 11.639

10.  Evidence for trans splicing in trypanosomes.

Authors:  R E Sutton; J C Boothroyd
Journal:  Cell       Date:  1986-11-21       Impact factor: 41.582

View more
  43 in total

1.  The spliced leader-associated RNA is a trypanosome-specific sn(o) RNA that has the potential to guide pseudouridine formation on the SL RNA.

Authors:  Xue-Hai Liang; Yu-Xin Xu; Shulamit Michaeli
Journal:  RNA       Date:  2002-02       Impact factor: 4.942

Review 2.  Unconventional rules of small nuclear RNA transcription and cap modification in trypanosomatids.

Authors:  Christian Tschudi; Elisabetta Ullut
Journal:  Gene Expr       Date:  2002

Review 3.  Enzymology of RNA cap synthesis.

Authors:  Agnidipta Ghosh; Christopher D Lima
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-25       Impact factor: 9.957

4.  Complete cap 4 formation is not required for viability in Trypanosoma brucei.

Authors:  Jesse R Zamudio; Bidyottam Mittra; Gusti M Zeiner; Marcin Feder; Janusz M Bujnicki; Nancy R Sturm; David A Campbell
Journal:  Eukaryot Cell       Date:  2006-06

5.  Characterization of a Trypanosoma brucei RNA cap (guanine N-7) methyltransferase.

Authors:  Megan P Hall; C Kiong Ho
Journal:  RNA       Date:  2006-01-23       Impact factor: 4.942

6.  The 2'-O-ribose methyltransferase for cap 1 of spliced leader RNA and U1 small nuclear RNA in Trypanosoma brucei.

Authors:  Jesse R Zamudio; Bidyottam Mittra; Silvie Foldynová-Trantírková; Gusti M Zeiner; Julius Lukes; Janusz M Bujnicki; Nancy R Sturm; David A Campbell
Journal:  Mol Cell Biol       Date:  2007-07-02       Impact factor: 4.272

7.  A protein related to the vaccinia virus cap-specific methyltransferase VP39 is involved in cap 4 modification in Trypanosoma brucei.

Authors:  George K Arhin; Hongjie Li; Elisabetta Ullu; Christian Tschudi
Journal:  RNA       Date:  2005-11-21       Impact factor: 4.942

8.  Novel and essential subunits in the 300-kilodalton nuclear cap binding complex of Trypanosoma brucei.

Authors:  Hongjie Li; Christian Tschudi
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

9.  A novel class of developmentally regulated noncoding RNAs in Leishmania.

Authors:  Carole Dumas; Conan Chow; Michaela Müller; Barbara Papadopoulou
Journal:  Eukaryot Cell       Date:  2006-10-27

10.  Roles of a Trypanosoma brucei 5'->3' exoribonuclease homolog in mRNA degradation.

Authors:  Chi-Ho Li; Henriette Irmer; Drifa Gudjonsdottir-Planck; Simone Freese; Heike Salm; Simon Haile; Antonio M Estévez; Christine Clayton
Journal:  RNA       Date:  2006-10-31       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.